Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gladding P et al. – Increasing the dose of clopidogrel in patients with nonresponder polymorphisms can increase antiplatelet response. Personalizing clopidogrel dosing using pharmacogenomics may be an effective method of optimizing treatment.


Related Articles

A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
The American Journal of Cardiology, 10/28/09    Relevance Score: 89%

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09    Relevance Score: 89%

Gender and Responses to Aspirin and Clopidogrel: Insights Using Short Thrombelastography
Cardiovascular Drug Reviews, 11/17/09    Relevance Score: 87%

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Vascular Health and Risk Management, 10/22/09    Relevance Score: 87%

Effects of clopidogrel on aspirin specific pathways of platelet inhibition
Platelets, 10/02/09    Relevance Score: 87%

Today in Clinical Pharmacology...keeping you current

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes
Diabetic Medicine, 02/09/10

OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine
Expert Opinion on Biological Therapy, 02/09/10

Capsaicin jelly against migraine pain
International Journal of Clinical Practice, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address